These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 26991296)

  • 1. Membrane permeabilization of colistin toward pan-drug resistant Gram-negative isolates.
    Mohamed YF; Abou-Shleib HM; Khalil AM; El-Guink NM; El-Nakeeb MA
    Braz J Microbiol; 2016; 47(2):381-8. PubMed ID: 26991296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Anthelmintic Drug Niclosamide Synergizes with Colistin and Reverses Colistin Resistance in Gram-Negative Bacilli.
    Domalaon R; De Silva PM; Kumar A; Zhanel GG; Schweizer F
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro antimicrobial activity of "last-resort" antibiotics against unusual nonfermenting Gram-negative bacilli clinical isolates.
    Jacquier H; Le Monnier A; Carbonnelle E; Corvec S; Illiaquer M; Bille E; Zahar JR; Jauréguy F; Fihman V; Tankovic J; Cattoir V;
    Microb Drug Resist; 2012 Aug; 18(4):396-401. PubMed ID: 22335615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of colistin against multidrug-resistant gram-negative bacteria isolated at a major army hospital during the military campaigns in Iraq and Afghanistan.
    Paolino K; Erwin D; Padharia V; Carrero H; Giron L; Burgess R; Burger C; Martinez M; Arrieta P; Wortmann G; Zapor M
    Clin Infect Dis; 2007 Jul; 45(1):140-1. PubMed ID: 17554723
    [No Abstract]   [Full Text] [Related]  

  • 5. MCR: modern colistin resistance.
    Caniaux I; van Belkum A; Zambardi G; Poirel L; Gros MF
    Eur J Clin Microbiol Infect Dis; 2017 Mar; 36(3):415-420. PubMed ID: 27873028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colonization and infection by colistin-resistant Gram-negative bacteria in a cohort of critically ill patients.
    Kontopidou F; Plachouras D; Papadomichelakis E; Koukos G; Galani I; Poulakou G; Dimopoulos G; Antoniadou A; Armaganidis A; Giamarellou H
    Clin Microbiol Infect; 2011 Nov; 17(11):E9-E11. PubMed ID: 21939468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of tigecycline against multiple-drug-resistant, including pan-resistant, gram-negative and gram-positive clinical isolates from Greek hospitals.
    Souli M; Kontopidou FV; Koratzanis E; Antoniadou A; Giannitsioti E; Evangelopoulou P; Kannavaki S; Giamarellou H
    Antimicrob Agents Chemother; 2006 Sep; 50(9):3166-9. PubMed ID: 16940120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of the type I signal peptidase inhibitor MD3 against multidrug-resistant Gram-negative bacteria alone and in combination with colistin.
    Personne Y; Curtis MA; Wareham DW; Waite RD
    J Antimicrob Chemother; 2014 Dec; 69(12):3236-43. PubMed ID: 25134721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria.
    Li J; Nation RL; Milne RW; Turnidge JD; Coulthard K
    Int J Antimicrob Agents; 2005 Jan; 25(1):11-25. PubMed ID: 15620821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging Gram negative resistance to last-line antimicrobial agents fosfomycin, colistin and ceftazidime-avibactam - epidemiology, laboratory detection and treatment implications.
    Sherry N; Howden B
    Expert Rev Anti Infect Ther; 2018 Apr; 16(4):289-306. PubMed ID: 29543500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
    Kasiakou SK; Michalopoulos A; Soteriades ES; Samonis G; Sermaides GJ; Falagas ME
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3136-46. PubMed ID: 16048915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymyxins for the treatment of extensively-drug-resistant Gram-negative bacteria: from pharmacokinetics to bedside.
    Zavascki AP
    Expert Rev Anti Infect Ther; 2014 May; 12(5):531-3. PubMed ID: 24666285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of faecal carriage of colistin-resistant Gram-negative rods in a university hospital in western France, 2016.
    Saly M; Jayol A; Poirel L; Megraud F; Nordmann P; Dubois V
    J Med Microbiol; 2017 Jun; 66(6):842-843. PubMed ID: 28598315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small molecule downregulation of PmrAB reverses lipid A modification and breaks colistin resistance.
    Harris TL; Worthington RJ; Hittle LE; Zurawski DV; Ernst RK; Melander C
    ACS Chem Biol; 2014 Jan; 9(1):122-7. PubMed ID: 24131198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic evaluation of colistin sodium.
    Michalopoulos AS; Karatza DC; Gregorakos L
    Expert Opin Drug Metab Toxicol; 2011 Feb; 7(2):245-55. PubMed ID: 21128824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colistin: still a lifesaver for the 21st century?
    Karaiskos I; Souli M; Galani I; Giamarellou H
    Expert Opin Drug Metab Toxicol; 2017 Jan; 13(1):59-71. PubMed ID: 27573251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous colistin sulfate: a rarely used form of polymyxin E for the treatment of severe multidrug-resistant Gram-negative bacterial infections.
    Huang J; Tang YQ; Sun JY
    Scand J Infect Dis; 2010 Apr; 42(4):260-5. PubMed ID: 20085424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extensively drug-resistant and pandrug-resistant Gram-negative bacteria in a tertiary-care hospital in Eastern India: A 4-year retrospective study.
    Mohapatra DP; Debata NK; Singh SK
    J Glob Antimicrob Resist; 2018 Dec; 15():246-249. PubMed ID: 30144638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of colistin-resistant bacteria in humans without colistin usage: a new worry and cause for vigilance.
    Olaitan AO; Morand S; Rolain JM
    Int J Antimicrob Agents; 2016 Jan; 47(1):1-3. PubMed ID: 26712133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is colistin effective in the treatment of infections caused by multidrug-resistant (MDR) or extremely drug-resistant (XDR) gram-negative microorganisms in children?
    Ozsurekci Y; Aykac K; Cengiz AB; Bayhan C; Sancak B; Karadag Oncel E; Kara A; Ceyhan M
    Diagn Microbiol Infect Dis; 2016 Jun; 85(2):233-8. PubMed ID: 27041107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.